Commission Directive 2009/2/EC of 15 January 2009 amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances (Text with EEA relevance)
Commission Directive 2009/2/ECof 15 January 2009amending, for the purpose of its adaptation to technical progress, for the 31st time, Council Directive 67/548/EEC on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substances(Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the European Community,Having regard to Council Directive 67/548/EEC of 27 June 1967 on the approximation of the laws, regulations and administrative provisions relating to the classification, packaging and labelling of dangerous substancesOJ 196, 16.8.1967, p. 1., and in particular Article 28 thereof,Whereas:(1)Article 4(3) of Directive 67/548/EEC sets out the criteria and the procedure to be followed to harmonise the classification and labelling of substances. Paragraphs 4.1.3, 4.1.4 and 4.1.5 of Annex VI to Directive 67/548/EEC oblige industry to provide information to Member States and Member States to make proposals for harmonised classification and labelling as a matter of urgency, when information becomes available justifying that a substance fulfils the criteria as a mutagenic, carcinogenic or reproductive toxic chemical.(2)Annex I to Directive 67/548/EEC contains a list of dangerous substances, together with particulars of the classification and labelling of each substance. That list needs to be updated to include further notified new substances and further existing substances, as well as to adapt certain entries to technical progress. In addition, it is necessary, in that Annex, to delete entries for certain substances.(3)Annex I to Directive 67/548/EEC already contains numerous group entries in particular for metal compounds evaluated using a grouping and read across approach based on analogy between substances.(4)Annex I to Directive 67/548/EEC also contains certain groups where members of the group are identified and where the classification was derived by applying grouping and read across approaches, notably the petroleum streams and gasses.(5)Annex VI to Directive 67/548/EEC states that the data required for classification and labelling may be obtained from a number of different sources, including the results of validated structure-activity relationships and expert judgement.(6)The classifications of the nickel compounds listed in this Directive are based on the effects originating from the Ni(2+) ion and on the available data for nickel compounds. The classifications were derived by grouping nickel compounds into categories on the basis of water solubility (e.g. groups insoluble, slightly soluble and soluble nickel compounds respectively). Water solubility was used as an initial criterion to define these categories, based on the argument that nickel substances having similar water solubility will indicate similar bioavailability of the Ni(2+) ion and similar systemic toxicity. This justifies a read across within groups from the substances for which the available adequate test data demonstrate a specific systemic effect to those lacking such test data. For some effects, read across between groups is justified, as similar effects have been observed across the range of water solubility. For example, epidemiological studies show that both soluble and insoluble nickel compounds (at opposite ends of the range of solubility) have local carcinogenic effects in the respiratory tract. There is, therefore, good reason to conclude that slightly soluble compounds (at the middle of this range) have similar carcinogenic properties.(7)As part of an evaluation of all the available information for the nickel compounds, water solubility can be used as an approximation of systemic bioavailability of the Ni(2+) ion for many effects and substances.(8)The classification and labelling of the substances listed in this Directive should be reviewed if new scientific knowledge becomes available. In this context, noting in particular that the nickel industry has recently submitted preliminary, partial and not peer-reviewed information, special attention should be paid to the outcome of future discussions within the World Health Organisation's International Agency for Research on Cancer on the carcinogenicity of nickel substances, or to any relevant new scientific findings or interpretations of the data used to establish the classifications for the nickel compounds included in this Directive.(9)The measures provided for in this Directive are in accordance with the opinion of the Committee on the Adaptation to Technical Progress of the Directives for the Elimination of Technical Barriers to Trade with Dangerous Substances and Preparations,HAS ADOPTED THIS DIRECTIVE:
Article 1Directive 67/548/EEC is amended as follows. Annex I is amended as follows:(a)the entries corresponding to the entries set out in Annex 1A to this Directive are replaced by the entries set out in that Annex;(b)the entries set out in Annex 1B to this Directive are inserted in accordance with the order of the entries set out in Annex I to Directive 67/548/EEC;(c)the entries set out in Annex 1C to this Directive are deleted.
Article 2Member States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 1 June 2009 at the latest. They shall forthwith communicate to the Commission the text of those provisions and a correlation table between those provisions and this Directive.When Member States adopt those provisions, they shall contain a reference to this Directive or be accompanied by such a reference on the occasion of their official publication. Member States shall determine how such reference is to be made.Member States shall communicate to the Commission the text of the main provisions of national law which they adopt in the field covered by this Directive.
Article 3This Directive shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union.
Article 4This Directive is addressed to the Member States.
Done at Brussels, 15 January 2009.For the CommissionStavros DimasMember of the CommissionANNEX 1A
Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
001-002-00-4aluminium lithium hydride240-877-916853-85-3F; R15C; R35F; CR: 15-35S: (1/2-)7/8-26-36/37/39-43-45
005-006-00-7dibutyltin hydrogen borateE401-040-575113-37-0Muta. Cat. 3; R68Repr. Cat. 2; R60-61T; R48/25Xn; R21/22Xi; R41R43N; R50-53T; NR: 60-61-21/22-41-43-48/25-68-50/53S: 53-45-60-61
006-007-00-5salts of hydrogen cyanide with the exception of complex cyanides such as ferrocyanides, ferricyanides and mercuric oxycyanide and those specified elsewhere in this AnnexAT+; R26/27/28R32N; R50-53T+; NR: 26/27/28-32-50/53S: (1/2-)7-28-29-45-60-61
006-015-00-9diuron (ISO);3-(3,4-dichlorophenyl)-1,1-dimethylurea206-354-4330-54-1Carc. Cat. 3; R40Xn; R22-48/22N; R50-53Xn; NR: 22-40-48/22-50/53S: (2-)13-36/37-46-60-61C ≥ 25 %: Xn, N; R22-40-48/22-50/5310 % ≤ C < 25 %: Xn, N; R40-48/22-50/532,5 % ≤ C < 10 %: Xn, N; R40-50/531 % ≤ C < 2,5 %: Xn, N; R40-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
006-076-00-1mancozeb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric) complex with zinc salt8018-01-7Repr. Cat. 3; R63R43N; R50Xn; NR: 43-63-50S: (2-)36/37-46-61C ≥ 5 %: Xn, N; R43-63-502,5 ≤ C < 5 %: Xi, N; R43-501 % ≤ C < 2,5 %: Xi; R43
006-077-00-7maneb (ISO);manganese ethylenebis(dithiocarbamate) (polymeric)235-654-812427-38-2Repr. Cat. 3; R63Xn; R20Xi; R36R43N; R50-53Xn; NR: 20-36-43-63-50/53S: (2-)36/37-46-60-61C ≥ 25 %: Xn, N; R20-36-43-63-50/5320 % ≤ C < 25 %: Xn, N; R36-43-63-50/535 % ≤ C < 20 %: Xn, N; R43-63-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
006-084-00-5carbosulfan (ISO);2,3-dihydro-2,2-dimethyl-7-benzofuryl [(dibutylamino)thio]methylcarbamate259-565-955285-14-8T+; R26T; R25R43N; R50-53T+; NR: 25-26-43-50/53S: (1/2-)28-36/37-38-45-63-60-61
006-088-00-7benfuracarb (ISO);ethyl N-[2,3-dihydro-2,2-dimethylbenzofuran-7-yloxycarbonyl(methyl)aminothio]-N-isopropyl-β-alaninate82560-54-1Repr. Cat. 3; R62T; R23Xn; R22N; R50-53T; NR: 22-23-62-50/53S: (1/2-)36/37-45-60-61
007-002-00-0nitrogen dioxide; [1]dinitrogen tetraoxide [2]233-272-6 [1]234-126-4 [2]10102-44-0 [1]10544-72-6 [2]O; R8T+; R26C; R34O; T+R: 8-26-34S: (1/2-)9-26-28-36/37/39-45C ≥ 10 %: T+; R26-345 % ≤ C < 10 %: T; R23-341 % ≤ C < 5 %: T; R23-36/37/380,5 % ≤ C < 1 %: Xn; R20-36/37/380,1 % ≤ C < 0,5 %: Xn; R205
015-041-00-Xmalathion (ISO);1,2-bis(ethoxycarbonyl)ethyl O,O-dimethyl phosphorodithioate;[containing ≤ 0,03 % isomalathion]204-497-7121-75-5Xn; R22R43N; R50-53Xn; NR: 22-43-50/53S: (2-)24-37-46-60-61C ≥ 25 %: Xn, N; R22-43-50/531 % ≤ C < 25 %: Xi, N; R43-50/530,025 % ≤ C < 1 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53
015-100-00-Xphoxim (ISO);α-(diethoxyphosphinothioylimino) phenylacetonitrile238-887-314816-18-3Repr. Cat. 3; R62Xn; R22R43N; R50-53Xn; NR: 22-43-62-50/53S: (2-)36/37-46-60-61C ≥ 25 %: Xn, N; R22-43-62-50/535 % ≤ C < 25 %: Xn, N; R43-62-50/531 % ≤ C < 5 %: Xi, N; R43-50/530,025 % ≤ C < 1 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53
015-102-00-0tris(2-chloroethyl)phosphateE204-118-5115-96-8Carc. Cat. 3; R40Repr. Cat. 2; R60Xn; R22N; R51-53T; NR: 60-22-40-51/53S: 53-45-61
015-155-00-Xglufosinate ammonium (ISO);ammonium 2-amino-4-(hydroxymethylphosphinyl)butyrateE278-636-577182-82-2Repr. Cat. 2; R60Repr. Cat. 3; R63Xn; R20/21/22-48/20/22TR: 60-20/21/22-48/20/22-63S: 53-45
016-009-00-8disodium sulfide;sodium sulfide215-211-51313-82-2T; R24Xn; R22C; R34R31N; R50T; C; NR: 22-24-31-34-50S: (1/2-)26-36/37/39-45-61
017-009-00-0ammonium perchlorate;[containing ≥ 80 % of 0-30 μm particles]T232-235-17790-98-9E; R3O; R9ER: 3-9S: (2-)14-16-36/37
024-004-00-7sodium dichromateE234-190-310588-01-9O; R8Carc. Cat. 2; R45Muta. Cat. 2; R46Repr. Cat. 2; R60-61T+; R26T; R25-48/23Xn; R21C; R34R42/43N; R50-53O; T+; NR: 45-46-60-61-8-21-25-26-34-42/43-48/23-50/53S: 53-45-60-61C ≥ 25 %: T+, N; R45-46-60-61-21-25-26-34-42/43-48/23-50/5310 % ≤ C < 25 %: T+, N; R45-46-60-61-22-26-34-42/43-48/23-51/537 % ≤ C < 10 %: T+, N; R45-46-60-61-22-26-36/37/38-42/43-48/20-51/535 % ≤ C < 7 %: T, N; R45-46-60-61-22-23-36/37/38-42/43-48/20-51/533 % ≤ C < 5 %: T, N; R45-46-60-61-22-23-42/43-48/20-51/532,5 % ≤ C < 3 %: T, N; R45-46-60-61-23-42/43-48/20-51/531 % ≤ C < 2,5 %: T; R45-46-60-61-23-42/43-48/20-52/530,5 % ≤ C < 1 %: T; R45-46-60-61-20-42/43-52/530,25 % ≤ C < 0,5 %: T; R45-46-20-42/43-52/530,2 % ≤ C < 0,25 %: T; R45-46-20-42/430,1 % ≤ C < 0,2 %: T; R45-46-203
027-002-00-4cobalt oxide215-154-61307-96-6Xn; R22R43N; R50-53Xn; NR: 22-43-50/53S: (2-)24-37-60-61C ≥ 25 %: Xn, N; R22-43-50/532,5 % ≤ C < 25 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
027-003-00-Xcobalt sulfide215-273-31317-42-6R43N; R50-53Xi; NR: 43-50/53S: (2-)24-37-60-61C ≥ 2,5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
028-003-00-2nickel monoxide; [1]nickel oxide; [2]bunsenite [3]E215-215-7 [1]234-323-5 [2]- [3]1313-99-1 [1]11099-02-8 [2]34492-97-2 [3]Carc. Cat. 1; R49T; R48/23R43R53TR: 49-43-48/23-53S: 53-45-61
028-004-00-8nickel dioxideE234-823-312035-36-8Carc. Cat. 1; R49T; R48/23R43R53TR: 49-43-48/23-53S: 53-45-61
028-005-00-3dinickel trioxideE215-217-81314-06-3Carc. Cat. 1; R49T; R48/23R43R53TR: 49-43-48/23-53S: 53-45-61
028-006-00-9nickel (II) sulfide; [1]nickel sulfide; [2]millerite [3]E240-841-2 [1]234-349-7 [2]- [3]16812-54-7 [1]11113-75-0 [2]1314-04-1 [3]Carc. Cat. 1; R49Muta. Cat. 3; R68T; R48/23R43N; R50-53T; NR: 49-43-48/23-68-50/53S: 53-45-60-61
028-007-00-4trinickel disulfide;nickel subsulfide; [1]heazlewoodite [2]E234-829-6 [1]- [2]12035-72-2 [1]12035-71-1 [2]Carc. Cat. 1; R49Muta. Cat. 3; R68T; R48/23R43N; R50-53T; NR: 49-43-48/23-68-50/53S: 53-45-60-61
028-008-00-Xnickel dihydroxide; [1]nickel hydroxide [2]E235-008-5 [1]234-348-1 [2]12054-48-7 [1]11113-74-9 [2]Carc. Cat. 1; R49Repr. Cat. 2; R61Muta. Cat. 3; R68T; R48/23Xn; R20/22Xi; R38R42/43N; R50-53T; NR: 49-61-20/22-38-42/43-48/23-68-50/53S: 53-45-60-61
029-013-00-Xtrisodium(2-(α-(3-(4-chloro-6-(2-(2-(vinylsulfonyl)ethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-2-oxido-5-sulfonatophenylazo)benzylidenehydrazino)-4-sulfonatobenzoato)copper(II)407-580-8130201-51-3Xi; R41XiR: 41S: (2-)26-39
033-005-00-1arsenic acid and its salts with the exception of those specified elsewhere in this AnnexAECarc. Cat. 1; R45T; R23/25N; R50-53T; NR: 45-23/25-50/53S: 53-45-60-61
034-002-00-8selenium compounds with the exception of cadmium sulphoselenide and those specified elsewhere in this AnnexAT; R23/25R33N; R50-53T; NR: 23/25-33-50/53S: (1/2-)20/21-28-45-60-61
047-001-00-2silver nitrate231-853-97761-88-8O; R8C; R34N; R50-53O; C; NR: 8-34-50/53S: (1/2-)26-36/37/39-45-60-61
050-002-00-0cyhexatin (ISO);hydroxytricyclohexylstannane;tri(cyclohexyl)tin hydroxide236-049-113121-70-5Xn; R20/21/22N; R50-53Xn; NR: 20/21/22-50/53S: (2-)13-60-61C ≥ 25 %: Xn, N; R20/21/22-50/530,025 % ≤ C < 25 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53
050-003-00-6fentin acetate (ISO);triphenyltin acetate212-984-0900-95-8Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53T+; NR: 24/25-26-37/38-40-41-48/23-63-50/53S: (1/2-)26-28-36/37/39-45-60-61C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/5320 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/5310 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/537 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/535 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/533 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/532,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/531 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/530,25 % ≤ C < 1 %: Xn, N; R20-51/530,1 % ≤ C < 0,25 %: Xn; R20-52/530,025 % ≤ C < 0,1 %: R52/53
050-004-00-1fentin hydroxide (ISO);triphenyltin hydroxide200-990-676-87-9Carc. Cat. 3; R40Repr. Cat. 3; R63T+; R26T; R24/25-48/23Xi; R37/38-41N; R50-53T+; NR: 24/25-26-37/38-40-41-48/23-63-50/53S: (1/2-)26-28-36/37/39-45-60-61C ≥ 25 %: T+, N; R24/25-26-37/38-40-41-48/23-63-50/5320 % ≤ C < 25 %: T+, N; R21/22-26-37/38-40-41-48/23-63-50/5310 % ≤ C < 20 %: T+, N; R21/22-26-40-41-48/23-63-50/537 % ≤ C < 10 %: T+, N; R21/22-26-36-40-48/20-63-50/535 % ≤ C < 7 %: T, N; R21/22-23-36-40-48/20-63-50/533 % ≤ C < 5 %: T, N; R21/22-23-40-48/20-50/532,5 % ≤ C < 3 %: T, N; R23-40-48/20-50/531 % ≤ C < 2,5 %: T, N; R23-40-48/20-51/530,25 % ≤ C < 1 %: Xn, N; R20-51/530,1 % ≤ C < 0,25 %: Xn; R20-52/530,025 % ≤ C < 0,1 %: R52/53
050-008-00-3tributyltin compounds, with the exception of those specified elsewhere in this AnnexAT; R25-48/23/25Xn; R21Xi; R36/38N; R50-53T; NR: 21-25-36/38-48/23/25-50/53S: (1/2-)36/37/39-45-60-61C ≥ 2,5 %: T, N; R21-25-36/38-48/23/25-50/531 % ≤ C < 2,5 %: T, N; R21-25-36/38-48/23/25-51/530,25 % ≤ C < 1 %: Xn, N; R22-48/20/22-51/530,025 % C < 0,25 %: R52/531
050-011-00-Xtriphenyltin compounds, with the exception of those specified elsewhere in this AnnexAT; R23/24/25N; R50-53T; NR: 23/24/25-50/53S: (1/2-)26-27-28-45-60-61C ≥ 1 %: T, N; R23/24/25-50/530,25 % ≤ C < 1 %: Xn, N; R20/21/22-50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/531
050-018-00-8tin(II) methanesulphonate401-640-753408-94-9C; R34Xn; R22R43N; R51-53C; NR: 22-34-43-51/53S: (1/2-)22-26-36/37/39-45-61
053-003-00-4iodoxybenzene696-33-3E; R2ER: 2S: (2-)35
053-004-00-Xcalcium iodoxybenzoateCE; R2ER: 2S: (2-)35
080-001-00-0mercuryE231-106-77439-97-6Repr. Cat. 2; R61T+; R26T; R48/23N; R50-53T+; NR: 61-26-48/23-50/53S: 53-45-60-61
080-010-00-Xmercury dichloride;mercuric chloride231-299-87487-94-7Muta. Cat. 3; R68Repr. Cat. 3; R62T+; R28T; R48/24/25C; R34N; R50-53T+; NR: 28-34-48/24/25-62-68-50/53S: (1/2-)26-36/37/39-45-60-61
092-002-00-3uranium compounds with the exception of those specified elsewhere in this AnnexAT+; R26/28R33N; R51-53T+; NR: 26/28-33-51/53S: (1/2-)20/21-45-61
601-065-00-3A mixture of: (1′α,3′α,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane);(1′α,3′β,6′α)-2,2,3′,7′,7′-pentamethylspiro(1,3-dioxane-5,2′-norcarane)416-930-9Xi; R38N; R51-53Xi; NR: 38-51/53S: (2-)36/37-61
602-007-00-Xbromoform;tribromomethane200-854-675-25-2T; R23Xn; R22Xi; R36/38N; R51-53T; NR: 22-23-36/38-51/53S: (1/2-)28-45-63-61
602-030-00-51,3-dichloropropene; [1](Z)-1,3-dichloropropene [2]C D208-826-5 [1]233-195-8 [2]542-75-6 [1]10061-01-5 [2]R10T; R24/25Xn; R20-65Xi; R36/37/38R43N; R50-53T; NR: 10-20-24/25-36/37/38-43-65-50/53S: (1/2-)36/37-45-60-61
602-054-00-63-iodpropene;allyl iodide209-130-4556-56-9F; R11C; R34F; CR: 11-34S: (1/2-)7-16-26-45
603-005-00-12-methylpropan-2-ol;tert-butyl alcohol200-889-775-65-0F; R11Xn; R20Xi; R36/37F; XnR: 11-20-36/37S: (2-)9-16-46
603-018-00-2furfuryl alcohol202-626-198-00-0Carc. Cat. 3; R40T; R23Xn; R21/22-48/20Xi; R36/37TR: 21/22-23-36/37-40-48/20S: (1/2-)36/37-45-63
603-023-00-Xethylene oxide;oxiraneE200-849-975-21-8F+; R12R6Carc. Cat. 2; R45Muta. Cat. 2; R46T; R23Xi; R36/37/38F+; TR: 45-46-6-12-23-36/37/38S: 53-45
603-029-00-2bis(2-chloroethyl) ether203-870-1111-44-4Carc. Cat. 3; R40T+; R26/27/28T+R: 26/27/28-40S: (1/2-)7/9-27-28-36/37-45C ≥ 7 %: T+; R26/27/28-401 % ≤ C < 7 %: T; R23/24/25-400,1 % ≤ C < 1 %: Xn; R20/21/22
603-037-00-6cellulose nitrate;nitrocelluloseTE; R3ER: 3S: (2-)35
603-046-00-5bis(chloromethyl) ether;oxybis(chloromethane)E208-832-8542-88-1F; R11Carc. Cat. 1; R45T+; R26T; R24Xn; R22F; T+R: 45-11-22-24-26S: 53-45C ≥ 25 %: T+; R45-22-24-267 % ≤ C < 25 %: T+; R45-21-263 % ≤ C < 7 %: T; R45-21-231 % ≤ C < 3 %: T; R45-230,1 % ≤ C < 1 %: T; R45-200,001 % ≤ C < 0,1 %: T; R45
603-064-00-31-methoxy-2-propanol;monopropylene glycol methyl ether203-539-1107-98-2R10R67R: 10-67S: (2-)
603-066-00-41,2-epoxy-4-epoxyethylcyclohexane;4-vinylcyclohexene diepoxide203-437-7106-87-6Carc. Cat. 3; R40T; R23/24/25TR: 23/24/25-40S: (1/2-)36/37-45-63C ≥ 1 %: T; R23/24/25-400,1 % ≤ C < 1 %: Xn; R20/21/22
605-004-00-12,4,6-trimethyl-1,3,5-trioxane;paraldehyde204-639-8123-63-7R10R: 10S: (2-)29
605-005-00-72,4,6,8-tetramethyl-1,3,5,7-tetraoxacyclooctane;metaldehyde203-600-2108-62-3F; R11Xn; R22F; XnR: 11-22S: (2-)13-16-25-46
606-021-00-7N-methyl-2-pyrrolidone;1-methyl-2-pyrrolidone212-828-1872-50-4Repr. Cat. 2; R61Xi; R36/37/38TR: 61-36/37/38S: 53-45C ≥ 10 %: T; R61-36/37/385 % ≤ C < 10 %: T; R61
607-007-00-3salts of oxalic acid with the exception of those specified elsewhere in this AnnexAXn; R21/22XnR: 21/22S: (2-)24/25C ≥ 5 %: Xn; R21/22
607-012-00-0benzoyl chloride202-710-898-88-4Xn; R20/21/22C; R34R43CR: 20/21/22-34-43S: (1/2-)26-36/37/39-45
607-037-00-72-ethoxyethyl acetate;ethylglycol acetateE203-839-2111-15-9R10Repr. Cat. 2; R60-61Xn; R20/21/22TR: 60-61-10-20/21/22S: 53-45
607-051-00-3MCPA (ISO);4-chloro-o-tolyloxyacetic acid202-360-694-74-6Xn; R22Xi; R38-41N; R50-53Xn; NR: 22-38-41-50/53S: (2-)26-37-39-60-61
607-052-00-9salts and esters of MCPAAXn; R20/21/22N; R50-53Xn; NR: 20/21/22-50/53S: (2-)13-60-61
607-085-00-9benzyl benzoate204-402-9120-51-4Xn; R22N; R51-53Xn; NR: 22-51/53S: (2-)25-46-61
607-095-00-3maleic acid203-742-5110-16-7Xn; R22Xi; R36/37/38R43XnR: 22-36/37/38-43S: (2-)24-26-28-37-46C ≥ 25 %: Xn; R22-36/37/38-4320 % ≤ C <25 %: Xi; R36/37/38-430,1 % ≤ C < 20 %: Xi; R43
607-103-00-5succinic anhydride203-570-0108-30-5Xn; R22Xi; R36/37XnR: 22-36/37S: (2-)25-46C ≥ 5 %: Xn; R22-36/371 % ≤ C < 5 %: Xi; R36/37
607-142-00-8propyl chloroformate;chloroformic acid propylester;n-propyl chloroformate203-687-7109-61-5F; R11T; R23C; R34F; TR: 11-23-34S: (1/2-)16-26-36-45
607-195-00-72-methoxy-1-methylethyl acetate203-603-9108-65-6R10R: 10S: (2-)
607-216-00-Xglutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine403-950-8T+; R26Xn; R22C; R34N; R50T+; NR: 22-26-34-50S: (1/2-)26-36/37/39-38-45-61
607-231-00-1clopyralid (ISO);3,6-dichloropyridine-2-carboxylic acid216-935-41702-17-6Xi; R41XiR: 41S: (2-)26-39
607-245-00-8tert-butyl acrylateD216-768-71663-39-4F; R11Xn; R20/21/22Xi; R37/38R43N; R51-53F; Xn; NR: 11-20/21/22-37/38-43-51/53S: (2-)16-25-37-61C ≥ 25 %: Xn; R20/21/22-37/38-43-51/5320 % ≤ C < 25 %: Xi; R37/38-43-52/532,5 % ≤ C < 20 %: Xi; R43-52/531 % ≤ C < 2,5 %: Xi; R43
607-397-00-5A mixture of: Ca salicylates (branched C10-14 and C18-30 alkylated);Ca phenates (branched C10-14 and C18-30 alkylated);Ca sulfurised phenates (branched C10-14 and C18-30 alkylated)415-930-6Repr. Cat. 3; R62R43XnR: 43-62S: (2-)23-36/37
608-005-00-5n-butyronitrile203-700-6109-74-0F; R11T; R23/24/25F; TR: 11-23/24/25S: (1/2-)16-36/37-45-63
608-011-00-8oxalonitrile;cyanogen207-306-5460-19-5F+; R12T; R23N; R50-53F+; T; NR: 12-23-50/53S: (1/2-)9-16-23-33-45-63-60-61
608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0Xn; R22N; R51-53Xn; NR; 22-51/53S: (2-)46-61
609-007-00-92,4-dinitrotoluene; [1]dinitrotoluene [2]E204-450-0 [1]246-836-1 [2]121-14-2 [1]25321-14-6 [2]Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R23/24/25Xn; R48/22N; R50-53T; NR: 45-23/24/25-48/22-62-68-50/53S: 53-45-60-61
611-028-00-3C,C′-azodi(formamide)204-650-8123-77-3E; R2R42E; XnR: 2-42S: (2-)22-24-37
611-035-00-1tetralithium 6-amino-4-hydroxy-3-[7-sulfonato-4-(5-sulfonato-2-naphthylazo)-1-naphthylazo]naphthalene-2,7-disulfonate403-660-1107246-80-0N; R51-53NR: 51/53S: 61
612-044-00-3N,N′-diacetylbenzidineE210-338-2613-35-4Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R20/21/22TR: 45-20/21/22-68S: 53-45
612-050-00-6cyclohexylamine203-629-0108-91-8R10Repr. Cat. 3; R62Xn; R21/22C; R34CR: 10-21/22-34-62S: (1/2-)26-36/37/39-45C ≥ 25 %: C; R21/22-34-6210 % ≤ C < 25 %: C; R34-625 % ≤ C < 10 %: Xn; R36/38-622 % ≤ C < 5 %: Xi; R36/38
612-076-00-8ethyldimethylamine209-940-8598-56-1F; R11Xn; R20/22C; R34F; CR: 11-20/22-34S: (1/2-)3-16-26-36-45
612-099-00-34-methyl-m-phenylenediamine;2,4-toluenediamineE202-453-195-80-7Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R25Xn; R21-48/22R43N; R51-53T; NR: 45-21-25-43-48/22-62-68-51/53S: 53-45-61
612-101-00-2methenamine;hexamethylenetetramine202-905-8100-97-0F; R11R43F; XiR: 11-43S: (2-)24-37
612-151-00-5methyl-phenylene diamine;diaminotoluene;[technical product - mixture of 4-methyl-m-phenylene diamine (EC No 202-453-1) and 2-methyl-m-phenylene diamine (EC No 212-513-9)]ECarc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62T; R25Xn; R21-48/22Xi; R36R43N; R51-53T; NR: 45-21-25-36-43-48/22-62-68-51/53S: 53-45-61
612-237-00-2hydroxylammonium hydrogensulfate;hydroxylamine sulfate(1:1); [1]hydroxylamine phosphate; [2]hydroxylamine dihydrogenphosphate; [3]hydroxylamine 4-methylbenzenesulfonate [4]T233-154-4 [1]244-077-0 [2]242-818-2 [3]258-872-5 [4]10046-00-1 [1]20845-01-6 [2]19098-16-9 [3]53933-48-5 [4]E; R2Carc. Cat. 3; R40Xn; R21/22-48/22Xi; R36/38R43N; R50E; Xn; NR: 21/22-36/38-40-43-48/22-50S: (2-)36/37-61
613-116-00-7tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]211-986-9731-27-1T+; R26T; R48/23Xi; R36/37/38R43N; R50T+; NR: 26-36/37/38-43-48/23-50S: (1/2-)28-36/37/39-45-63-61C ≥ 20 %: T+, N; R26-36/37/38-43-48/23-5010 % ≤ C < 20 %: T+, N; R26-43-48/23-507 % ≤ C < 10 %: T+, N; R26-43-48/20-502,5 % ≤ C < 7 %: T, N; R23-43-48/20-501 % ≤ C < 2,5 %: T; R23-43-48/200,1 % ≤ C < 1 %: Xn; R20
615-001-00-7methyl isocyanate210-866-3624-83-9F; R11Repr. Cat. 3; R63T+; R26T; R24/25R42/43Xi; R37/38-41F; T+R: 11-24/25-26-37/38-41-42/43-63S: (1/2-)16-26-27/28-36/37/39-45-63
615-004-00-3salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexAXn; R20/21/22R32R52-53XnR: 20/21/22-32-52/53S: (2-)13-36/37-46-61
615-028-00-4ethyl 2-(isocyanatosulfonyl)benzoate410-220-277375-79-2R14Xn; R22-48/22Xi; R41R42/43XnR: 14-22-41-42/43-48/22S: (2-)8-23-26-30-35-36/37/39
615-030-00-5alkali salts and alkali earth salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexAXn; R20/21/22R32R52-53XnR: 20/21/22-32-52/53S: (2-)13-36/37-46-61
615-031-00-0thallium thiocyanate222-571-73535-84-0T+; R26/28Xn; R21R32R33N; R51-53T+; NR: 21-26/28-32-33-51/53S: (1/2-)13-28-36/37-45-61
615-032-00-6metal salts of thiocyanic acid, with the exception of those specified elsewhere in this AnnexAXn; R20/21/22R32N; R50-53Xn; NR: 20/21/22-32-50/53S: (2-)13-36/37-46-60-61
616-124-00-9lithium bis(trifluoromethylsulfonyl)imide415-300-090076-65-6T; R24/25Xn; R48/22C; R34R52-53TR: 24/25-34-48/22-52/53S: (1/2-)22-26-36/37/39-45-61
617-017-00-XA mixture of: 2,2′-bis(tert-pentylperoxy)-p-diisopropylbenzene;2,2′-bis(tert-pentylperoxy)-m-diisopropylbenzeneT412-140-332144-25-5E; R2O; R7R53ER: 2-7-53S: (2-)3/7-14-36/37/39-61
650-016-00-2Mineral wool, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+MgO+BaO) content greater than 18 % by weight]AQRCarc. Cat. 3; R40XnR: 40S: (2-)36/37
650-017-00-8Refractory Ceramic Fibres, Special Purpose Fibres, with the exception of those specified elsewhere in this Annex;[Man-made vitreous (silicate) fibres with random orientation with alkaline oxide and alkali earth oxide (Na2O+K2O+CaO+ MgO+BaO) content less or equal to 18 % by weight]ARCarc. Cat. 2; R49TR: 49S: 53-45
ANNEX 1B
Index NoChemical nameNotes related to substancesEC NoCAS NoClassificationLabellingConcentration LimitsNotes related to preparations
003-003-00-5(2-methylpropyl)lithium;isobutyllithium440-620-2920-36-5F; R15-17R14C; R35R67N; R50-53F; C; NR: 14/15-17-35-67-50/53S: (1/2-)6-16-26-30-33-36/37/39-43-45-60-61
005-013-00-5diethylmethoxyborane425-380-97397-46-8F; R17Xn; R20/21/22-48/22C; R34R43R53F; CR: 17-20/21/22-34-43-48/22-53S: (1/2-)6-26-36/37/39-43-45-61
005-014-00-04-formylphenylboronic acid438-670-587199-17-5R43XiR: 43S: (2-)24-37
005-017-00-7sodium perborate; [1]perboric acid, sodium salt; [2]perboric acid, sodium salt, monohydrate; [3]sodium peroxometaborate; [4]perboric acid (HBO(O2)), sodium salt, monohydrate; [5]sodium peroxoborate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]E239-172-9 [1]234-390-0 [2]- [3]231-556-4 [4]- [5]15120-21-5 [1]11138-47-9 [2]12040-72-1 [3]7632-04-4 [4]10332-33-9 [5]O; R8Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R22Xi; R37-41O; TR: 61-8-22-37-41-62S: 53-45C ≥ 25 %: T; R61-22-37-41-6222 % ≤ C < 25 %: T; R61-37-41-6220 % ≤ C < 22 %: T; R61-36/37-6214 % ≤ C < 20 %: T; R61-36-629 % ≤ C < 14 %: T; R61-626,5 % ≤ C < 9 %: T; R61
005-017-01-4sodium perborate; [1]perboric acid, sodium salt; [2]perboric acid, sodium salt, monohydrate; [3]sodium peroxometaborate; [4]perboric acid (HBO(O2)), sodium salt, monohydrate; [5]sodium peroxoborate;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]E239-172-9 [1]234-390-0 [2]- [3]231-556-4 [4]- [5]15120-21-5 [1]11138-47-9 [2]12040-72-1 [3]7632-04-4 [4]10332-33-9 [5]O; R8Repr. Cat. 2; R61Repr. Cat. 3; R62T; R23Xn; R22Xi; R37-41O; TR: 61-8-22-23-37-41-62S: 53-45C ≥ 25 %: T; R61-22-23-37-41-6222 % ≤ C < 25 %: T; R61-20-37-41-6220 % ≤ C < 22 %: T; R61-20-36/37-6214 % ≤ C < 20 %: T; R61-20-36-629 % ≤ C < 14 %: T; R61-20-626,5 % ≤ C < 9 %: T; R61-203 % ≤ C < 6,5 %: Xn; R20
005-018-00-2perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]perboric acid, sodium salt, tetrahydrate; [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]sodium peroxoborate hexahydrate;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]- [1]- [2]- [3]13517-20-9 [1]37244-98-7 [2]10486-00-7 [3]Repr. Cat. 2; R61Repr. Cat. 3; R62Xi; R37-41TR: 61-37-41-62S: 53-45-47C ≥ 36 %: T; R61-37-41-6222 % ≤ C < 36 %: T; R61-36/37-6220 % ≤ C < 22 %: T; R61-37-6214 % ≤ C < 20 %: T; R61-6210 % ≤ C < 14 %: T; R61
005-018-01-Xperboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]perboric acid, sodium salt, tetrahydrate; [2]perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]sodium peroxoborate hexahydrate;[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]E- [1]- [2]- [3]13517-20-9 [1]37244-98-7 [2]10486-00-7 [3]Repr. Cat. 2; R61Repr. Cat. 3; R62Xn; R20Xi; R37-41TR: 61-20-37-41-62S: 53-45-47C ≥ 36 %: T; R61-20-37-41-6225 % ≤ C < 36 %: T; R61-20-36/37-6222 % ≤ C < 25 %: T; R61-36/37-6220 % ≤ C < 22 %: T; R61-37-6214 % ≤ C < 20 %: T; R61-6210 % ≤ C < 14 %: T; R61
006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2Xn; R22-48/22R52-53XnR: 22-48/22-52/53S: (2-)22-36-61
006-098-00-1tert-butyl (1R,5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0Xn; R22-48/22Xi; R41R43XnR: 22-41-43-48/22S: (2-)22-26-36/37/39
006-099-00-7N-(p-toluenesulfonyl)-N′-(3-(p-toluenesulfonyloxy)phenyl)urea;3-({[(4-methylphenyl)sulfonyl]carbamoyl}amino)phenyl 4-methylbenzenesulfonate432-520-2232938-43-1N; R51-53NR: 51/53S: 22-61
006-101-00-6mixture of: N,N″-(methylenedi-4,1-phenylene)bis[N′-phenylurea];N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N′-cyclohexylurea;N,N″-(methylenedi-4,1-phenylene)bis[N′-cyclohexylurea]423-070-8R53R: 53S: 61
006-102-00-1O-hexyl-N-ethoxycarbonylthiocarbamateE432-750-3Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R22-48/22R43N; R51-53T; NR: 45-46-22-43-48/22-51/53S: 53-45-61
006-103-00-7N,N″-(methylenedi-4,1-phenylene)bis[N′-octyl]urea445-760-8Xi; R41R42N; R50-53Xn; NR: 41-42-50/53S: (2-)22-26-39-45-60-61C ≥10 %: Xn, N; R41-42-50/535 % ≤ C < 10 %: Xn, N; R36-42-50/531 % ≤ C < 5 %: Xn, N; R42-50/530,25 % ≤ C < 1 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 ≤ C < 0,025 %: R52/53
007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9Xn; R21/22C; R35CR: 21/22-35S: (1/2-)26-36/37/39-45
012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1N; R50-53NR: 50/53S: 60-61
014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6Repr.Cat.2; R60N; R50-53T; NR: 60-50/53S: 53-45-60-61C ≥ 0,5 %: T, N; R60-50/530,025 % ≤ C < 0,5 %: N; R50/530,0025 % ≤ C < 0,025 %: N; R51/530,00025 % ≤ C < 0,0025 %: R52/53
014-037-00-52-butanone-O,O′,O′′-(phenylsilylidyne)trioxime433-360-634036-80-1Xn; R48/22R43R52-53XnR: 43-48/22-52/53S: (2-)36/37-61
014-038-00-0S-(3-(triethoxysilyl)propyl)octanethioate436-690-9220727-26-4R43XiR: 43S: (2-)24-37
014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0Xi; R38-41R52-53XiR: 38-41-52/53S: (2-)26-37/39-61
014-041-00-7N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9Xn; R22R43XnR: 22-43S: (2-)24-37
014-042-00-2mixture of: O,O′,O″,O′′′-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0Xi; R41XiR: 41S: (2-)26-39
014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2F; R11Xi; R37/38-41R52-53F; XiR: 11-37/38-41-52/53S: (2-)6-26-36/39-61
014-044-00-33-[(4′-acetoxy-3′-methoxyphenyl) propyl]trimethoxysilane433-050-0N; R51-53NR: 51/53S: 61
014-045-00-9magnesium sodium fluoride silicate442-650-1Xn; R48/20XnR: 48/20S: (2-)22-36
015-190-00-0bis(2,4-dicumylphenyl) neopentyl diphosphite;3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane421-920-2154862-43-8R53R: 53S: 61
015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2Xi; R38R52-53XiR: 38-52/53S: (2-)37-61
015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3R43R53XiR: 43-53S: (2-)24-37-61
015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3T; R25Xi; R41N; R50-53T; NR: 25-41-50/53S: (1/2-)26-39-45-60-61
015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3Xn; R22R52-53XnR: 22-52/53S: (2-)61
015-195-00-8mixture of: potassium o-toluenephosphonate;potassium m-toluenephosphonate;potassium p-toluenephosphonate433-860-4Xi; R36R43R52-53XiR: 36-43-52/53S: (2-)24-26-37-61
015-196-00-3mixture of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate435-960-3Carc.Cat.2; R45Muta.Cat.2; R46R43TR: 45-46-43S: 53-45
015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7R10T; R23Xn; R22C; R34N; R51-53T; NR: 10-22-23-34-51/53S: (1/2-)9-26-36/37/39-45-61
015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1Carc.Cat.3; R40Xi; R41XnR: 40-41S: (2-)23-26-36/37/39
016-094-00-1sulfur231-722-67704-34-9Xi; R38XiR: 38S: (2-)46
016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3Xn; R22C; R34R43R52-53CR: 22-34-43-52/53S: (1/2-)22-26-36/37/39-45-61
017-009-01-8ammonium perchlorate;[containing < 80 % of 0-30 μm particles]T232-235-17790-98-9E; R2O; R9ER: 2-9S: (2-)14-16-36/37
022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc.Cat.3; R40XnR: 40S: (2-)22-36/37
022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6F; R11C; R34R43R53F; CR: 11-34-43-53S: (1/2-)6-9-16-26-36/37/39-45-61
028-002-01-4nickel powder;[particle diameter < 1 mm]231-111-47440-02-0Carc. Cat. 3; R40T; R48/23R43R52-53TR: 40-43-48/23-52/53S: (2-)36/37/39-45-61
028-013-00-7nickel matteE, H273-749-669012-50-6Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfateE295-859-392129-57-2Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22Xi; R38R42/43N; R50-53T; NR: 49-61-20/22-38-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-20/22-38-42/43-48/23-68-50/5320 % ≤ C < 25 %: T, N; R49-61-38-42/43-48/23-68-51/532,5 % ≤ C < 20 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-015-00-8slimes and sludges, copper electrolyte refining, decopperisedE, H305-433-194551-87-8Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 1; R61Repr. Cat. 3; R62T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-62-68-50/53S: 53-45-60-61
028-016-00-3nickel diperchlorate;perchloric acid, nickel(II) saltE, H237-124-113637-71-3Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23C; R34R42/43N; R50-53T; NR: 49-61-34-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-34-42/43-48/23-68-50/535 % ≤ C < 25 %: T, N; R49-61-34-42/43-48/23-68-51/532,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-017-00-9nickel dipotassium bis(sulfate); [1]diammonium nickel bis(sulfate) [2]E, H237-563-9 [1]239-793-2 [2]13842-46-1 [1]15699-18-0 [2]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22R42/43N; R50-53T; NR: 49-61-20/22-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-018-00-4nickel bis(sulfamidate);nickel sulfamateE, H237-396-113770-89-3Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-019-00-Xnickel bis(tetrafluoroborate)E, H238-753-414708-14-6Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-021-00-0nickel diformate; [1]formic acid, nickel salt; [2]formic acid, copper nickel salt [3]E, H222-101-0 [1]239-946-6 [2]268-755-0 [3]3349-06-2 [1]15843-02-4 [2]68134-59-8 [3]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5%: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C 0,1 %: Xi; R43
028-022-00-6nickel di(acetate); [1]nickel acetate [2]E, H206-761-7 [1]239-086-1 [2]373-02-4 [1]14998-37-9 [2]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23Xn; R20/22R42/43N; R50-53T; NR: 49-61-20/22-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-20/22-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-024-00-7nickel dibenzoateE, H209-046-8553-71-9Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-025-00-2nickel bis(4-cyclohexylbutyrate)E, H223-463-23906-55-6Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-026-00-8nickel(II) stearate;nickel(II) octadecanoateE, H218-744-12223-95-2Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-027-00-3nickel dilactateE, H16039-61-5Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-028-00-9nickel(II) octanoateE, H225-656-74995-91-9Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat 2; R61T; R48/23C; R35R42/43N; R50-53T; C; NR: 49-61-35-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, C, N; R49-61-35-42/43-48/23-68-50/5310 % ≤ C < 25 %: T, C, N; R49-61-35-42/43-48/23-68-51/535 % ≤ C < 10 %: T, N; R49-61-34-42/43-48/23-68-51/532,5 % ≤ C < 5 %: T, N; R49-61-36/38-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-36/38-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-029-00-4nickel difluoride; [1]nickel dibromide; [2]nickel diiodide; [3]nickel potassium fluoride [4]E, H233-071-3 [1]236-665-0 [2]236-666-6 [3]- [4]10028-18-9 [1]13462-88-9 [2]13462-90-3 [3]11132-10-8 [4]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; 49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; 49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-030-00-Xnickel hexafluorosilicateE, H247-430-726043-11-8Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-031-00-5nickel selenateE, H239-125-215060-62-5Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-032-00-0nickel hydrogen phosphate; [1]nickel bis(dihydrogen phosphate); [2]trinickel bis(orthophosphate); [3]dinickel diphosphate; [4]nickel bis(phosphinate); [5]nickel phosphinate; [6]phosphoric acid, calcium nickel salt; [7]diphosphoric acid, nickel(II) salt [8]E, H238-278-2 [1]242-522-3 [2]233-844-5 [3]238-426-6 [4]238-511-8 [5]252-840-4 [6]- [7]- [8]14332-34-4 [1]18718-11-1 [2]10381-36-9 [3]14448-18-1 [4]14507-36-9 [5]36026-88-7 [6]17169-61-8 [7]19372-20-4 [8]Carc. Cat. 1; R49T; R48/23R42/43N; R50-53T; NR: 49-42/43-48/23-50/53S: 53-45-60-61
028-033-00-6diammonium nickel hexacyanoferrateE, H74195-78-1Carc. Cat. 1; R49T; R48/23R42/43N; R50-53T; NR: 49-42/43-48/23-50/53S: 53-45-60-61
028-034-00-1nickel dicyanideE, H209-160-8557-19-7Carc. Cat. 1; R49T; R48/23R42/43R32N; R50-53T; NR: 49-32-42/43-48/23-50/53S: 53-45-60-61
028-035-00-7nickel chromateE, H238-766-514721-18-7Carc. Cat. 1; R49T; R48/23R42/43N; R50-53T; NR: 49-42/43-48/23-50/53S: 53-45-60-61
028-036-00-2nickel(II) silicate; [1]dinickel orthosilicate; [2]nickel silicate (3:4); [3]silicic acid, nickel salt; [4]trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]E, H244-578-4 [1]237-411-1 [2]250-788-7 [3]253-461-7 [4]235-688-3 [5]21784-78-1 [1]13775-54-7 [2]31748-25-1 [3]37321-15-6 [4]12519-85-6 [5]Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-037-00-8dinickel hexacyanoferrateE, H238-946-314874-78-3Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-038-00-3trinickel bis(arsenate);nickel(II) arsenateE, H236-771-713477-70-8Carc. Cat. 1; R45T; R48/23R43N; R50-53T; NR: 45-43-48/23-50/53S: 53-45-60-61
028-039-00-9nickel oxalate; [1]oxalic acid, nickel salt [2]E, H208-933-7 [1]243-867-2 [2]547-67-1 [1]20543-06-0 [2]Carc. Cat. 1; R49T; R48/23R43N: R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-040-00-4nickel tellurideE, H235-260-612142-88-0Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-041-00-Xtrinickel tetrasulfideE, H12137-12-1Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-042-00-5trinickel bis(arsenite)E, H74646-29-0Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-043-00-0cobalt nickel gray periclase;C.I. Pigment Black 25;C.I. 77332; [1]cobalt nickel dioxide; [2]cobalt nickel oxide [3]E, H269-051-6 [1]261-346-8 [2]- [3]68186-89-0 [1]58591-45-0 [2]12737-30-3 [3]Carc. Cat. 1; R49T; R48/23R43TR: 49-43-48/23S: 53-45
028-044-00-6nickel tin trioxide;nickel stannateE, H234-824-912035-38-0Carc. Cat. 1; R49T; R48/23R43TR: 49-43-48/23S: 53-45
028-045-00-1nickel triuranium decaoxideE, H239-876-615780-33-3Carc. Cat. 1; R49T; R48/23R43TR: 49-43-48/23S: 53-45
028-046-00-7nickel dithiocyanateE, H237-205-113689-92-4Carc. Cat. 1; R49Muta. Cat. 3;R68Repr. Cat. 2; R61T; R48/23R42/43R32N; R50-53T; NR: 49-61-32-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T: R49-61-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-047-00-2nickel dichromateE, H239-646-515586-38-6Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; 49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1% ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C 0,1 %: Xi; R43
028-048-00-8nickel(II) seleniteE, H233-263-710101-96-9Carc. Cat. 1; R49T; R48/23R42/43N; R50-53T; NR: 49-42/43-48/23-50/53S: 53-45-60-61
028-049-00-3nickel selenideE, H215-216-21314-05-2Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-050-00-9silicic acid, lead nickel saltE, H68130-19-8Carc. Cat. 1: R49Repr. Cat. 1: R61Repr. Cat. 3; R62T; R48/23R43N; R50-53T; NR: 49-61-43-48/23-62-50/53S: 53-45-60-61
028-051-00-4nickel diarsenide; [1]nickel arsenide [2]E, H235-103-1 [1]248-169-1 [2]12068-61-0 [1]27016-75-7 [2]Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-052-00-Xnickel barium titanium primrose priderite;C.I. Pigment Yellow 157;C.I. 77900E, H271-853-668610-24-2Carc. Cat. 1: R49T; R48/23R43TR: 49-43-48/23S: 53-45
028-053-00-5nickel dichlorate; [1]nickel dibromate; [2]ethyl hydrogen sulfate, nickel(II) salt [3]E, H267-897-0 [1]238-596-1 [2]275-897-7 [3]67952-43-6 [1]14550-87-9 [2]71720-48-4 [3]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N: R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T: R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T: R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-054-00-0nickel(II) trifluoroacetate; [1]nickel(II) propionate; [2]nickel bis(benzenesulfonate); [3]nickel(II) hydrogen citrate; [4]citric acid, ammonium nickel salt; [5]citric acid, nickel salt; [6]nickel bis(2-ethylhexanoate); [7]2-ethylhexanoic acid, nickel salt; [8]dimethylhexanoic acid nickel salt; [9]nickel(II) isooctanoate; [10]nickel isooctanoate; [11]nickel bis(isononanoate); [12]nickel(II) neononanoate; [13]nickel(II) isodecanoate; [14]nickel(II) neodecanoate; [15]neodecanoic acid, nickel salt; [16]nickel(II) neoundecanoate; [17]bis(D-gluconato-O1,O2)nickel; [18]nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]nickel(II) palmitate; [20](2-ethylhexanoato-O)(isononanoato-O)nickel; [21](isononanoato-O)(isooctanoato-O)nickel; [22](isooctanoato-O)(neodecanoato-O)nickel; [23](2-ethylhexanoato-O)(isodecanoato-O)nickel; [24](2-ethylhexanoato-O)(neodecanoato-O)nickel; [25](isodecanoato-O)(isooctanoato-O)nickel; [26](isodecanoato-O)(isononanoato-O)nickel; [27](isononanoato-O)(neodecanoato-O)nickel; [28]fatty acids, C6-19-branched, nickel salts; [29]fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]E, H240-235-8 [1]222-102-6 [2]254-642-3 [3]242-533-3 [4]242-161-1 [5]245-119-0 [6]224-699-9 [7]231-480-1 [8]301-323-2 [9]249-555-2 [10]248-585-3 [11]284-349-6 [12]300-094-6 [13]287-468-1 [14]287-469-7 [15]257-447-1 [16]300-093-0 [17]276-205-6 [18]258-051-1 [19]237-138-8 [20]287-470-2 [21]287-471-8 [22]284-347-5 [23]284-351-7 [24]285-698-7 [25]285-909-2 [26]284-348-0 [27]287-592-6 [28]294-302-1 [29]283-972-0 [30]- [31]16083-14-0 [1]3349-08-4 [2]39819-65-3 [3]18721-51-2 [4]18283-82-4 [5]22605-92-1 [6]4454-16-4 [7]7580-31-6 [8]93983-68-7 [9]29317-63-3 [10]27637-46-3 [11]84852-37-9 [12]93920-10-6 [13]85508-43-6 [14]85508-44-7 [15]51818-56-5 [16]93920-09-3 [17]71957-07-8 [18]52625-25-9 [19]13654-40-5 [20]85508-45-8 [21]85508-46-9 [22]84852-35-7 [23]84852-39-1 [24]85135-77-9 [25]85166-19-4 [26]84852-36-8 [27]85551-28-6 [28]91697-41-5 [29]84776-45-4 [30]72319-19-8 [31]Carc. Cat. 1; R49Muta. Cat. 3; R68Repr. Cat. 2; R61T; R48/23R42/43N; R50-53T; NR: 49-61-42/43-48/23-68-50/53S: 53-45-60-61C ≥ 25 %: T, N; R49-61-42/43-48/23-68-50/532,5 % ≤ C < 25 %: T, N; R49-61-42/43-48/23-68-51/531 % ≤ C < 2,5 %: T; R49-61-42/43-48/23-68-52/530,5 % ≤ C < 1 %: T; R49-61-43-48/20-52/530,25 % ≤ C < 0,5 %: T; R49-43-48/20-52/530,1 % ≤ C < 0,25 %: T; R49-43-48/200,01 % ≤ C < 0,1 %: Xi; R43
028-055-00-6nickel(II) sulfite; [1]nickel tellurium trioxide; [2]nickel tellurium tetraoxide; [3]molybdenum nickel hydroxide oxide phosphate [4]E, H231-827-7 [1]239-967-0 [2]239-974-9 [3]268-585-7 [4]7757-95-1 [1]15851-52-2 [2]15852-21-8 [3]68130-36-9 [4]Carc. Cat. 1; R49T; R48/23R42/43N; R50-53T; NR: 49-42/43-48/23-50/53S: 53-45-60-61
028-056-00-1nickel boride (NiB); [1]dinickel boride; [2]trinickel boride; [3]nickel boride; [4]dinickel silicide; [5]nickel disilicide; [6]dinickel phosphide; [7]nickel boron phosphide [8]E, H234-493-0 [1]234-494-6 [2]234-495-1 [3]235-723-2 [4]235-033-1 [5]235-379-3 [6]234-828-0 [7]- [8]12007-00-0 [1]12007-01-1 [2]12007-02-2 [3]12619-90-8 [4]12059-14-2 [5]12201-89-7 [6]12035-64-2 [7]65229-23-4 [8]Carc. Cat. 1; R49T; R48/23R43N; R50-53T; NR: 49-43-48/23-50/53S: 53-45-60-61
028-057-00-7dialuminium nickel tetraoxide; [1]nickel titanium trioxide; [2]nickel titanium oxide; [3]nickel divanadium hexaoxide; [4]cobalt dimolybdenum nickel octaoxide; [5]nickel zirkonium trioxide; [6]molybdenum nickel tetraoxide; [7]nickel tungsten tetraoxide; [8]olivine, nickel green; [9]lithium nickel dioxide; [10]molybdenum nickel oxide; [11]E, H234-454-8 [1]234-825-4 [2]235-752-0 [3]257-970-5 [4]268-169-5 [5]274-755-1 [6]238-034-5 [7]238-032-4 [8]271-112-7 [9]- [10]- [11]12004-35-2 [1]12035-39-1 [2]12653-76-8 [3]52502-12-2 [4]68016-03-5 [5]70692-93-2 [6]14177-55-0 [7]14177-51-6 [8]68515-84-4 [9]12031-65-1 [10]12673-58-4 [11]Carc. Cat. 1; R49T; R48/23R43TR: 49-43-48/23S: 53-45
028-058-00-2cobalt lithium nickel oxideE442-750-5Carc. Cat. 1; R49T+; R26T; R48/23R43N; R50-53T+; NR: 49-26-43-48/23-50/53S: 53-45-60-61
029-014-00-5mixture of: 2,2′-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N′,O,O′-copper complex;2,2′-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N′,O,O′-copper complex419-610-7171866-24-3Xn; R48/22N; R51-53Xn; NR: 48/22-51/53S: (2-)22-36-61
030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9R52-53R: 52/53S: 61
030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9N; R51-53NR: 51/53S: 61
042-005-00-0mixture of: mono- and di-glycerols of canola oil;canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];N,N-diorgano dithiocarbamate molybdenum complex434-240-6R43N; R51-53Xi; NR: 43-51/53S: (2-)24-37-61
050-023-00-5mixture of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane422-920-5Xn; R48/22N; R50-53Xn; NR: 48/22-50/53S: (2-)23-36-60-61C ≥ 10 %: Xn, N; R48/22-50/532,5 % ≤ C < 10 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
050-024-00-0mixture of: tri-p-tolyltin hydroxide;hexa-p-tolyl-distannoxane432-230-6T; R48/25Xn; R22Xi; R38-41R43N; R50-53T; NR: 22-38-41-43-48/25-50/53S: (1/2-)22-26-36/37/39-45-60-61
064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5N; R51-53NR: 51/53S: 61
078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6Xn; R22-48/20/21/22C; R35R42/43R52-53CR: 22-35-42/43-48/20/21/22-52/53S: (1/2-)23-24-26-28-36/37/39-45-61
078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1C; R35N; R50-53C; NR: 35-50/53S: (1/2-)26-36/37/39-45-60-61
082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5Xn; R22-48/22N; R51-53Xn; NR: 22-48/22-51/53S: (2-)22-36-61
601-080-00-5mixture of: sec-butylphenyl(phenyl)methane, mixed isomers;1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;1-(sec-butylphenyl-1-phenylethane, mixed isomers431-100-6N; R50-53NR: 50/53S: 60-61
601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9Xi; R38R43R53XiR: 38-43-53S: (2-)36/37-61
601-082-00-6mixture of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane434-420-4Xi; R38-41N; R50-53Xi; NR: 38-41-50/53S: (2-)23-26-37/39-57-60-61
601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3Xn; R65Xi; R38R53XnR: 38-65-53S: (2-)37-62-61
601-084-00-7mixture of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)435-180-3Xn; R65Xi; R38N; R50-53Xn; NR: 38-65-50/53S: (2-)37-62-60-61
602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5Xi; R41R43XiR: 41-43S: (2-)24-26-37/39
602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4Xn; R22N; R51-53Xn; NR: 22-51/53S: (2-)25-61
602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3Xn; R22Xi; R38N; R51-53Xn; NR: 22-38-51/53S: (2-)37-61
602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2Xn; R22Xi; R36R43XnR: 22-36-43S: (2-)26-36/37
603-211-00-12,3-epoxypropyltrimethylammonium chloride … %;glycidyl trimethylammonium chloride … %B E221-221-03033-77-0Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62Xn; R21/22-48/22Xi; R41R43R52-53TR: 45-21/22-41-43-48/22-62-68-52/53S: 53-45-61
603-212-00-71,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;galaxolide;(HHCB)214-946-91222-05-5N; R50-53NR: 50/53S: 60-61
603-213-00-22-methoxy-2-methylbutane;tert-amyl methyl ether213-611-4994-05-8F; R11Xn; R22R67F; XnR: 11-22-67S: (2-)9-16-23-33
603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2C; R34CR: 34S: (1/2-)23-26-36/37/39-45
603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0E; R2Xn; R22-48/22Xi; R41R43N; R50-53E; Xn; NR: 2-22-41-43-48/22-50/53S: (2-)22-26-36/37/39-60-61
603-216-00-9cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5Xi; R41R43R52-53XiR: 41-43-52/53S: (2-)24-26-37/39-61
603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4R43R53XiR: 43-53S: (2-)24-37/39-61
603-220-00-01-{benzyl[2-(2-methoxyphenoxy)ethyl]amino}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3R53R: 53S: 61
603-221-00-61-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]433-580-2214353-17-0Xn; R22C; R34N; R51-53C; NR: 22-34-51/53S: (1/2-)26-36/37/39-45-61
603-221-01-31-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]E433-580-2214353-17-0Carc. Cat. 2; R45Xn; R22C; R34N; R51-53T; NR: 45-22-34-51/53S: 53-45-61
603-222-00-1(2R,3S,4R,5R,7R,9R,10R,11S,12S,13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Xi; R36XiR: 36S: (2-)26
603-223-00-72-cyclopentylidene cyclopentanol;1,1′-bi(cyclopentyliden)-2-ol434-270-16261-30-9Xi; R38-41R52-53XiR: 38-41-52/53S: (2-)26-37/39-61
603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9R53R: 53S: 61
603-225-00-8erythromycin A9-oxime (E);(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-D-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)437-070-013127-18-9N; R51-53NR: 51/53S: 61
603-226-00-34,4′(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2R52-53R: 52/53S: 61
603-227-00-9α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate445-060-2203574-04-3O; R7N; R50-53O; NR: 7-50/53S: (2-)3/7-14-36/37/39-60-61
603-228-00-4(+/-)-(R*,R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;6-fluoro-2-(2-oxiranyl)chromane419-620-1R43N; R51-53Xi; NR: 43-51/53S: (2-)36/37-61
603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7Xi; R38-41R43N; R50-53Xi; NR: 38-41-43-50/53S: (2-)24-26-37/39-60-61
603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5Xi; R38-41R53XiR: 38-41-53S: (2-)26-37/39-61
603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6R52-53R: 52/53S: 22-61
603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6R53R: 53S: 61
603-233-00-1mixture of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol444-430-0N; R51-53NR: 51/53S: 61
603-234-00-7(1R,4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3Xi; R38N; R51-53Xi; NR: 38-51/53S: (2-)37-61
604-074-00-0tetrabromobisphenol-A;2,2′,6,6′-tetrabromo-4,4′-isopropylidenediphenol201-236-979-94-7N; R50-53NR: 50/53S: 60-61
604-075-00-64-(1,1,3,3-tetramethylbutyl)phenol;4-tert-octylphenol205-426-2140-66-9Xi; R38-41N; R50-53Xi; NR: 38-41-50/53S: (2-)26-37/39-60-61C ≥ 20 %: Xi, N; R38-41-50/5310 % ≤ C < 20 %: Xi, N; R41-50/535 % ≤ C < 10 %: Xi, N; R36-50/532,5 % ≤ C < 5 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
604-076-00-1phenolphthalein201-004-777-09-8Carc. Cat. 2; R45Muta. Cat. 3; R68Repr. Cat. 3; R62TR: 45-62-68S: 53-45C ≥ 5 %: T; R45-62-681 % ≤ C < 5 %: T; R45-68
604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6R53R: 53S: 61
604-079-00-84,4′-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0Repr.Cat.3; R62R43N; R51-53Xn; NR: 43-62-51/53S: (2-)22-36/37-61
604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1Xn; R20C; R35R43N; R51-53C; NR: 20-35-43-51/53S: (1/2-)26-28-36/37/39-45-61
604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1N; R50-53NR: 50/53S: 25-60-61
604-082-00-42-chloro-6-fluoro-phenolE433-890-82040-90-6Muta.Cat.2; R46Repr.Cat.3; R62Xn; R22C; R34R43N; R51-53T; NR: 46-22-34-43-62-51/53S: 53-45-61
604-083-00-X4,4′-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4R53R: 53S: 61
604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6Xn; R22R52-53XnR: 22-52/53S: (2-)23-61
604-087-00-1mixture of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4′-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol433-640-8F; R17R44R53FR: 17-44-53S: (2-)15-22-61
604-089-00-22-methyl-5-tert-butylthiophenol444-970-7R10Repr.Cat.3; R63Xn; R48/20/22-65Xi; R36/38R43R67N; R50-53Xn; NR: 10-36/38-43-48/20/22-63-65-67-50/53S: (2-)26-36/37-62-60-61
605-037-00-1trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde421-800-1120578-03-2R53R: 53S: 22-61
605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4Xn; R22Xi; R38R43N; R51-53Xn; NR: 22-38-43-51/53S: (2-)36/37-61
605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0Xn; R22Xi; R41R43XnR: 22-41-43S: (2-)22-24-26-37/39
606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7Xn; R48/22N; R50-53Xn; NR: 48/22-50/53S: (2-)36-60-61
606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Xn; R22XnR: 22S: (2-)22
606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7N; R51-53NR: 51/53S: 61
606-128-00-92,2′-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8R53R: 53S: 61
606-129-00-45-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;(2S,4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one423-090-7156732-13-7R53R: 53S: 61
606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5R43R52-53XiR: 43-52/53S: (2-)24-37-61
606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dioneE427-230-85571-36-8Repr. Cat. 2; R60Xn; R48/22N; R51-53T; NR: 60-48/22-51/53S: 53-45-61
606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3R43R52-53XiR: 43-52/53S: (2-)24-37-61
606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. Cat.3; R62XnR: 62S: (2-)22-36/37
606-135-00-7cyclohexadecanone438-930-82550-52-9R53R: 53S: 61
606-136-00-2(3S,6R,9S,12R,15S,18R,21S,24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4Xi; R36R53XiR: 36-53S: (2-)26-61
606-137-00-8trans-7,7′-dimethyl-(4H,4H′)-(2,2′)bi[benzo[1,4]thiazinylidene]-3,3′-dione444-750-0211387-26-7R53R: 53S: 22-61
606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0R10Xn; R22-48/22Xi; R38-41R43N; R50-53Xn; NR: 10-22-38-41-43-48/22-50/53S: (2-)23-26-36/37/39-60-61C ≥ 25 %: Xn, N; R22-38-41-43-48/22-50/5320 % ≤ C < 25 %: Xn, N; R38-41-43-48/22-50/5310 % ≤ C < 20 %: Xn, N; R41-43-48/22-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9R53R: 53S: 61
606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1Xn; R48/22N; R50-53Xn; NR: 48/22-50/53S: (2-)22-36-60-61
606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7Xi; R36XiR: 36S: (2-)26
606-142-00-5mixture of: (1RS,2SR,7SR,8SR,E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;(1RS,2SR,7SR,8SR,Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;(1RS,2SR,7SR,8SR,Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one434-290-9Xn; R22N; R51-53Xn; NR: 22-51/53S: (2-)61
607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0R43N; R51-53Xi; NR: 43-51/53S: (2-)22-24-37-61
607-618-00-5menadione sodium bisulfite;2-naphthalenesulfonic acid,1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt204-987-0130-37-0Xi; R36/38N; R50-53Xi; NR: 36/38-50/53S: (2-)24/25-60-61
607-619-00-0menadione nicotinamide bisulfite;1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)277-543-773581-79-0Xi; R36/38N; R50-53Xi; NR: 36/38-50/53S: (2-)24/25-60-61
607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3Carc. Cat. 3; R40Xn; R22Xi; R36XnR: 22-36-40S: (2-)26-36/37-46C ≥ 25 %: Xn; R22-36-4020 ≤ % C < 25 %: Xn; R36-405 ≤ % C < 20 %: Xn; R40
607-621-00-1milbemectin (ISO);[mixture of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]Xn; R20/22N; R50-53Xn; NR: 20/22-50/53S: (2-)46-60-61C ≥ 25 %: Xn, N; R20/22-50/530,25 % ≤ C < 25 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/53
607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. Cat. 3; R63XnR: 63S: (2-)36/37
607-623-00-2diisobutyl phthalate201-553-284-69-5Repr. Cat. 2; R61Repr. Cat. 3; R62TR: 61-62S: 53-45C ≥ 25 %: T; R61-625 % ≤ C < 25 %: Xn; R62
607-624-00-8perfluorooctane sulfonic acid;heptadecafluorooctane-1-sulfonic acid; [1]potassium perfluorooctanesulfonate;potassium heptadecafluorooctane-1-sulfonate; [2]diethanolamine perfluorooctane sulfonate; [3]ammonium perfluorooctane sulfonate;ammonium heptadecafluorooctanesulfonate; [4]lithium perfluorooctane sulfonate;lithium heptadecafluorooctanesulfonate [5]E217-179-8 [1]220-527-1 [2]274-460-8 [3]249-415-0 [4]249-644-6 [5]1763-23-1 [1]2795-39-3 [2]70225-14-8 [3]29081-56-9 [4]29457-72-5 [5]Carc. Cat. 3; R40Repr. Cat. 2; R61T; R48/25Xn; R20/22R64N; R51-53T; NR: 61-20/22-40-48/25-64-51/53S: 53-45-61
607-625-00-3clodinafop-propargyl (ISO)105512-06-9Xn; R22-48/22R43N; R50-53.Xn; NR: 22-43-48/22-50/53S: (2-)24-36/37-46-60-61C ≥ 25 %: Xn, N; R22-43-48/22-50/5310 % ≤ C < 25 %: Xn, N; R43-48/22-51/532,5 % ≤ C < 10 %: Xi, N; R43-51/530,25 % ≤ C < 2,5 %: Xi; R43-52/530,001 % ≤ C < 0,25 %: Xi; R43
607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2Carc.Cat.2; R45N; R50-53T; NR: 45-50/53S: 53-45-60-61
607-627-00-4[(4S,5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5R43XiR: 43S: (2-)22-24-37
607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Xi; R41XiR: 41S: (2-)26-39
607-629-00-5[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid419-270-1123599-82-6Xi; R36XiR: 36S: (2-)26
607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6Xn; R20C; R34R43R52-53CR: 20-34-43-52/53S: (1/2-)26-36/37/39-45-61
607-631-00-6mixture of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate442-300-8R43XiR: 43S: (2-)24-37
607-632-00-1N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5R53R: 53S: 61
607-633-00-7trisodium 5-{[4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl]amino}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3Xi; R41R43XiR: 41-43S: (2-)22-24-26-37/39
607-634-00-2(S)-(-)-2-acetoxypropionylchloride;(1S)-2-chloro-1-methyl-2-oxoethyl acetate420-610-436394-75-9Xn; R22C; R34R43CR: 22-34-43S: (1/2-)23-26-36/37/39-45
607-635-00-8trisodium N-(3-propionato)-L-aspartate422-090-4172737-80-3Xi; R41XiR: 41S: (2-)26-39
607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8R10Carc.Cat.3; R40C; R34R43CR: 10-34-40-43S: (1/2-)7/9-8-23-26-36/37/39-45
607-637-00-9disodium 8-amino-5-{4-[2-(sulfonatoethoxy)sulfonyl]phenylazo}naphthalene-2-sulfonate423-730-5250688-43-8Xi; R41XiR: 41S: (2-)26-39
607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7R53R: 53S: 61
607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6R53R: 53S: 61
607-641-00-02-(formylamino)-3-thiophenecarboxylic acid;2-formamido-3-thiophenecarboxylic acid431-930-943028-69-9Xn; R22R43XnR: 22-43S: (2-)22-24-37
607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3N; R50-53NR: 50/53S: 60-61
607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0R10Xi; R41R43XiR: 10-41-43S: (2-)24-26-37/39-43
607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Xi; R38XiR: 38S: (2-)37
607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Xi; R41XiR: 41S: (2-)22-26-39
607-646-00-8D-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;tert-butyl 2-[(4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate432-960-5124655-09-0Xn; R22XnR: 22S: (2-)25
607-647-00-35-acetoxy-2-(R,S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5Xn; R22R43N; R50Xn; NR: 22-43-50S: (2-)24-37-57-61
607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8C; R35R43CR: 35-43S: (1/2-)7/8-26-36/37/39-45
607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2R43XiR: 43S: (2-)24-37
607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8Xi; R41R43XiR: 41-43S: (2-)24-26-37/39
607-652-00-0ethyl N2-dodecanoyl-L-argininate hydrochloride434-630-660372-77-2Xi; R41N; R50Xi; NR: 41-50S: (2-)26-39-61
607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4N; R51-53NR: 51/53S: 61
607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4R43XiR: 43S: (2-)23-24-37
607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0R43N; R51-53Xi; NR: 43-51/53S: (2-)24-37-61
607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3Xi; R41R52-53XiR: 41-52/53S: (2-)22-26-39-61
607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Xi; R41XiR: 41S: (2-)22-26-39
607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0Xi; R41R52-53XiR: 41-52/53S: (2-)26-39-61
607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Xi; R41XiR: 41S: (2-)22-26-39
607-660-00-42-{4-[4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino]phenylazo]phenylazo}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Xi; R41XiR: 41S: (2-)22-26-39
607-661-00-X1,1-dimethylethyl 4′-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6R43R53XiR: 43-53S: (2-)22-24-37-61
607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0R43N; R50-53Xi; NR: 43-50/53S: (2-)24-37-60-61
607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3R53R: 53S: 61
607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0Xi; R41N; R51-53Xi; NR: 41-51/53S: (2-)26-39-61
607-665-00-1trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1R10R: 10S: 23
607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Xi; R36XiR: 36S: (2-)26
607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2Muta.Cat.3; R68R43XnR: 43-68S: (2-)23-36/37
607-668-00-8trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7Xi; R41R52-53XiR: 41-52/53S: (2-)22-26-39-61
607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9R43R53XiR: 43-53S: (2-)24-37-61
607-670-00-9dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate448-700-9500791-70-8Xn; R48/22Xi; R41R43N; R50-53Xn; NR: 41-43-48/22-50/53S: (2-)22-26-36/37/39-60-61C ≥ 10 %: Xn, N; R41-43-48/22-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6N; R51-53NR: 51/53S: 61
607-672-00-Xmixture of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate419-000-0R43N; R51-53Xi; NR: 43-51/53S: (2-)24-37-61
607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0Xn; R22R52-53XnR: 22-52/53S: (2-)61
607-674-00-0branched C10-alkyl benzoates421-090-1131298-44-7Xn; R20XnR: 20S: (2-)23
607-675-00-6mixture of: cis-9-octadecenedioic acid;cis-9-cis-12-octadecadienedioic acid;hexadecanedioic acid;octadecanedioic acid422-260-8Xi; R41N; R50-53Xi; NR: 41-50/53S: (2-)26-39-60-61
607-676-00-1mixture of: 2-methylnonanedioic acid;2,4-dimethyl-4-methoxycarbonylundecanedioic acid;2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid423-670-1Xi; R41R43XiR: 41-43S: (2-)24-26-37/39
607-677-00-72,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazolyl]methyl]amino]carbonyl}-L-valinate424-660-8Xn; R48/22Xi; R41R43XnR: 41-43-48/22S: (2-)22-26-36/37/39
607-678-00-2mixture of: ethyl (2R,3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;ethyl (2S,3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate427-090-8R43N; R51-53Xi; NR: 43-51/53S: (2-)23-25-36/37-61
607-679-00-8mixture of: 3-{5-[3-(4-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(methyl)ammonium di(acetate);3-{5-[4-(3-{1,6-dihydro-2-hydroxy-4-methyl-1-[3-(methylammonio)propyl]-6-oxo-3-pyridylazo}benzamido]phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate);3-{5-[3-(4-{1-[3-(dimethylammonio)propyl]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo}benzamido)phenylazo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl}propyl(dimethyl)ammonium di(acetate)431-440-5Xi; R41N; R51-53Xi; NR: 41-51/53S: (2-)22-26-39-61
607-680-00-3tert-butyl(6-{2-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl]vinyl}(4S,6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9R53R: 53S: 61
607-681-00-9mixture of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;dihexadecyl 9-nonyl-10-octylnonadecandioate;1-octadecyl,19-hexadecyl 9-nonyl-10-octylnonadecandioate;dioctadecyl 9-nonyl-10-octylnonadecandioate432-910-2R53R: 53S: 61
607-682-00-4complex mixture of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9R53R: 53S: 61
607-683-00-Xmixture of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)435-450-0R43N; R51-53Xi; NR: 43-51/53S: (2-)24-37-61
607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1Xi; R38R43XiR: 38-43S: (2-)24-37
607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7Xi; R38-41XiR: 38-41S: (2-)26-37/39
607-686-00-66,6′-bis(diazo-5,5′,6,6′-tetrahydro-5,5′-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5E; R2F; R11Carc. Cat. 3; R40E; XnR: 2-11-40S: (2-)7-22-36/37
607-687-00-1mixture of: 2-{3,6-bis-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,3-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3,6-bis-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (2-10 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %);2-{3-[(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino]-xanthylium-9-yl}-benzenesulfonate (7-20 %)442-800-6Xi; R38N; R51-53Xi; NR: 38-51/53S: (2-)37-61
607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2Xn; R22XnR: 22S: (2-)
607-689-00-2mixture of: methyl 1,4-dimethylcyclohexanecarboxylate ("para-isomer" including cis- and trans- isomers);methyl 1,3-dimethylcyclohexanecarboxylate ("meta-isomer" including cis- and trans-isomers)444-920-4R52-53R: 52/53S: 61
607-690-00-8dimethyl[2S,2S′]-6,6,6′6′-tetramethoxy-2,2′-[N,N′-bis(trifluoracetyl)-S,S′-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3R43XiR: 43S: (2-)24-37
607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6R53R: 53S: 61
607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4R53R: 53S: 61
607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7R53R: 53S: 61
607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0Xn; R22R43N; R50-53Xn; NR: 22-43-50/53S: (2-)22-36/37-60-61
608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2Xn; R22Xi; R41R43N; R51-53Xn; NR: 22-41-43-51/53S: (2-)24-26-37/39-61
608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3N; R51-53NR: 51/53S: 22-61
608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7N; R50-53NR: 50/53S: 22-60-61
608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5Xn; R22Xi; R41N; R51-53Xn; NR: 22-41-51/53S: (2-)22-26-39-61
608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4T; R25Xi; R41R43N; R50-53T; NR: 25-41-43-50/53S: (1/2-)9-26-36/37/39-45-60-61
608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2R52-53R: 52/53S: 61
609-069-00-7musk ketone;3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;4′-tert-butyl-2′,6′-dimethyl-3′,5′-dinitroacetophenone201-328-981-14-1Carc. Cat. 3; R40N; R50-53Xn; NR: 40-50/53S: (2-)36/37-46-60-61
611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3R52-53R: 52/53S: 61
611-155-00-44,4′-oxybis(benzenesulfonylazide)431-850-47456-68-0E; R3F; R11Xn; R48/22N; R50-53E; Xn; NR: 3-11-48/22-50/53S: (2-)14-22-33-35-36-60-61
611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6Repr. Cat. 3; R62Xn; R48/22N; R51-53Xn; NR: 48/22-62-51/53S: (2-)36/37-61
611-157-00-5benzenesulfonic acid, 3,3′-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;potassium sodium 3-[(E)-(6-{3,4-dihydroxy-2-[(Z)-(3-sulfonatophenyl)diazenyl]benzyl}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate432-590-4243869-48-9Xi; R36R52-53XiR: 36-52/53S: (2-)26-61
611-158-00-0reaction mixture of: 2,3,4,2′,3′,4′-hexahydroxy-5,5′-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8F; R11R53FR: 11-53S: (2-)3-12-16-33-61
611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6Xi; R41R52-53XiR: 41-52/53S: (2-)26-39-61
611-160-00-1mixture of: 1,1,1-tris(phenyl-4′-(3″-diazo-3″,4″-dihydro-4″-oxo-naphthalene-1″-sulfonato)ethane;1,1,1-tris(phenyl-4′-(6″-diazo-5″,6″-dihydro-5″-oxo-naphthalene-1″-sulfonato)ethane;reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)422-760-6F; R11R53FR: 11-53S: (2-)3-12-33-61
611-161-00-7trisodium [1,2′-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4′-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1′-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)423-100-1Xi; R41XiR: 41S: (2-)26-39
611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4Xn; R22Xi; R41N; R51-53Xn; NR: 22-41-51/53S: (2-)22-26-39-61
611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9Xn; R22Xi; R41N; R51-53Xn; NR: 22-41-51/53S: (2-)22-26-39-61
611-164-00-3mixture of: 2,2′-dimethyl-2,2′-azobutanenitrile;2-methylpentanenitrile-2-azo-2′-(2′-methylpropanenitrile);2,2′-dimethyl-2,2′-azoheptanenitrile;2-methylheptanenitrile-2-azo-2′-(2′-methylpropanenitrile);2-methylheptanenitrile-2-azo-2′-(2′-methylbutanenitrile)429-710-2R10R32R44Xn; R22N; R51-53Xn; NR: 10-22-32-44-51/53S: (2-)12-15-16-47-51-61
611-165-00-9mixture of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate431-830-5R52-53R: 52/53S: 61
611-166-00-4mixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate432-100-9Xi; R41R52-53XiR: 41-52/53S: (2-)26-39-61
611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4′-(4,8-disulfonato-2-naphthylazo)-5′-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cuprate(II)435-240-9R52-53R: 52/53S: 61
611-168-00-5mixture of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid435-440-6Xi; R41XiR: 41S: (2-)22-26-39
611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2R52-53R: 52/53S: 61
611-170-00-6mixture of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2)-1-phenylmethyl)azo-κ-N1)-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)435-880-9R52-53R: 52/53S: 22-61
611-171-00-1mixture of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate436-890-6Xi; R41R52-53XiR: 41-52/53S: (2-)22-26-39-61
611-172-00-7mixture of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate438-310-7E; R2Repr. Cat. 3; R62Xn; R22-48/22R52-53E; XnR: 2-22-48/22-62-52/53S: (2-)22-35-36/37-61
611-173-00-2mixture of: 3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(2-sulfonatooxyethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;3-[3-carbamoyl-5-(5-{4-chloro-6-[4-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt440-510-4Xi; R41R43XiR: 41-43S: (2-)22-26-36/37/39
611-174-00-8mixture of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo]-5-{4-chloro-[6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino]-1,3,5-triazin-2-ylamino}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt442-290-5457624-86-1Xi; R41XiR: 41S: (2-)22-26-39
611-175-00-3mixture of: trisodium 5-{4-chloro-6-[N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;disodium 5-{4-chloro-6-[N-ethyl-3-(vinylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 5-{4-chloro-6-[N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino]-1,3,5-triazin-2-ylamino}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate444-050-5Xi; R41R52-53XiR: 41-52/53S: (2-)22-26-39-61
611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2E; R2F; R11N; R51-53E; NR: 2-11-51/53S: (2-)22-61
611-177-00-4mixture of: pentasodium bis[6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);tetrasodium [6-anilino-3,5′-disulfonatonaphthalene-2-azobenzene-1,2′-diolato][6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III);trisodium bis[6-anilino-5′-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2′-diolato]cobaltate(III)444-290-0508202-43-5Xi; R41R43R52-53XiR: 41-43-52/53S: (2-)22-24-26-37/39-61
611-178-00-Xmixture of: pentasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-{(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-3-{(E)-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl]phenylazo}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate445-280-9Xi; R41R43R52-53XiR: 41-43-52/53S: (2-)24-26-37/39-61
611-179-00-5mixture of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate450-010-8Xi; R41R43XiR: 41-43S: (2-)22-24-26-37/39
611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide,diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide,diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7N; R51-53NR: 51/53S: 22-61
612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride … %B222-048-33327-22-8Carc. Cat. 3, R40R52-53XnR: 40-52/53S: 36/37-61
612-239-00-3biphenyl-3,3′,4,4′-tetrayltetraamine;diaminobenzidine202-110-691-95-2Carc. Cat. 2; R45Muta. Cat. 3; R68TR: 45-68S: 53-45
612-240-00-9pyrimethanil (ISO);N-(4,6-dimethylpyrimidin-2-yl)aniline53112-28-0N; R51-53NR: 51/53S: 61
612-241-00-4piperazine hydrochloride; [1]piperazine dihydrochloride; [2]piperazine phosphate [3]228-042-7 [1]205-551-2 [2]217-775-8 [3]6094-40-2 [1]142-64-3 [2]1951-97-9 [3]Repr. Cat. 3; R62-63Xi; R36/38R42/43R52-53XnR: 36/38-42/43-62-63-52/53S: (1/2-)22-36/37-45-63-61
612-242-00-Xcyprodinil (ISO);4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine121552-61-2R43N; R50-53Xi; NR: 43-50/53S: (2-)24-37-46-60-61C ≥ 2,5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3Xi; R41N; R50-53Xi; NR: 41-50/53S: (2-)26-39-60-61C ≥ 10 %: Xi, N; R41-50/535 % ≤ C < 10 %: Xi, N; R36-50/532,5 % ≤ C < 5 %: N; R50/530,25 % ≤ C < 2, 5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1Repr. Cat. 3; R62Xn; R22Xi; R36R43N; R50-53Xn; NR: 22-36-43-62-50/53S: (2-)22-26-36/37/39-60-61
612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2Carc. Cat. 3; R40T; R48/25Xn; R22Xi; R41R43N; R50-53T; NR: 22-40-41-43-48/25-50/53S: (1/2-)22-26-36/37/39-45-60-61C ≥ 25 %: T, N; R22-40-41-43-48/25-50/5310 % ≤ C < 25 %: T, N; R40-41-43-48/25-50/535 % ≤ C < 10 %: Xn, N; R36-40-43-48/22-50/532,5 % ≤ C < 5 %: Xn, N; R40-43-48/22-50/531 % ≤ C < 2,5 %: Xn, N; R40-43-48/22-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chlorideE429-740-640722-80-3Carc. Cat. 2; R45Muta. Cat. 2; R46Xn; R48/22R43R52-53TR: 45-46-43-48/22-52/53S: 53-45-61
612-247-00-7N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N′-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4T; R48/25Xn; R22R52-53TR: 22-48/25-52/53S: (1/2-)22-36-45-61
612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0Xi; R38R43R53XiR: 38-43-53S: (2-)24-37-61
612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2Repr. Cat. 3; R62Xn; R22C; R34R43N; R51-53C; NR: 22-34-43-62-51/53S: (1/2-)22-26-36/37/39-45-61
612-250-00-3chloro-N,N-dimethylformiminium chlorideE425-970-63724-43-4R14Repr. Cat. 2; R61Xn; R22C; R35T; CR: 61-14-22-35S: 53-45
612-251-00-9cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8F; R11Repr. Cat. 3; R63Xn; R22Xi; R38R43N; R51-53F; Xn; NR: 11-22-38-43-63-51/53S: (2-)7-22-33-36/37-61
612-252-00-4imidacloprid (ISO);1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine428-040-8138261-41-3Xn; R22N; R50-53Xn; NR: 22-50/53S: (2-)22-57-60-61
612-253-00-X7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing < 0,5 % formamide (EC No 200-842-0)]429-400-7199327-61-2R52-53R: R52/53S: 61
612-253-01-77-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;[containing ≥ 0,5 % formamide (EC No 200-842-0)]429-400-7199327-61-2Repr. Cat. 2; R61R52-53TR: 61-52/53S: 53-45-61
612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5Carc. Cat. 3; R40Xn; R22C; R34R43N; R51-53C; NR: 22-34-40-43-51/53S: (1/2-)13-25-26-36/37/39-45-61
612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4Xn; R21/22C; R34R52-53CR: 21/22-34-52/53S: (1/2-)26-36/37/39-45-61
612-256-00-6benzyl(S)-2-[(2′-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3Xn; R22R43XnR: 22-43S: (2-)36/37
612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Xn; R22XnR: 22S: (2-)22
612-259-00-2N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Xi; R41XiR: 41S: (2-)26-39
612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6Xn; R22R43N; R50-53Xn; NR: 22-43-50/53S: (2-)24-37-60-61C ≥ 25 %: Xn, N; R22-43-50/532,5 % ≤ C < 25 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7R52-53R: 52/53S: 61
612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0Muta. Cat. 3; R68Xn; R22-48/22N; R50-53Xn; NR: 22-48/22-68-50/53S: (2-)22-36/37-60-61
612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0R43R53XiR: 43-53S: (2-)36/37-61
612-269-00-7mixture of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;mixture of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline420-720-2R53R: 53S: 22-61
612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2Xn; R22R43R52-53XnR: 22-43-52/53S: (2-)22-36/37-61
612-271-00-8mixture of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate434-970-5160987-57-5R53R: 53S: 61
612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5N; R51-53NR: 51/53S: 61
612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8Xn; R22C; R35N; R50-53C; NR: 22-35-50/53S: (1/2-)26-36/37/39-45-60-61
612-274-00-4(R,S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3Xn; R22Xi; R41R43R52-53XnR: 22-41-43-52/53S: (2-)22-24-26-37/39-61
612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1Xi; R38-41R43N; R50-53Xi; NR: 38-41-43-50/53S: (2-)23-26-36/37/39-60-61C ≥ 20 %: Xi, N; R38-41-43-50/5310 % ≤ C < 20 %: Xi, N; R41-43-50/535 % ≤ C < 10 %: Xi, N; R36-43-50/532,5 % ≤ C < 5 %: Xi, N; R43-50/531 % ≤ C < 2,5 %: Xi, N; R43-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2Xi; R41R43R52-53XiR: 41-43-52/53S: (2-)22-24-26-36/37/39-61
612-277-00-0mixture of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;4-amino-5-hydroxy-6-(5-{4-chloro-6-[4-(2-sulfonatooxyethanesulfonyl)phenylamino]-1,3,5-triazin-2-ylamino}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium451-440-9586372-44-3Xi; R41XiR: 41S: (2-)22-26-39
612-278-00-6ethidium bromide;3,8-diamino-1-ethyl-6-phenylphenantridinium bromide214-984-61239-45-8Muta. Cat. 3; R68T+; R26Xn; R22T+R: 22-26-68S: (1/2-)28-36/37-45-63
612-279-00-1(R,S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8Repr. Cat. 3; R62Xn; R48/22Xi; R36/38R43XnR: 36/38-43-48/22-62S: (2-)22-26-36/37
612-280-00-73-amino-9-ethyl carbazole;9-ethylcarbazol-3-ylamineH205-057-7132-32-1Carc. Cat. 2; R45TR: 45S: 53-45
613-116-01-4tolylfluanid (ISO);dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]211-986-9731-27-1Xi; R36/37/38R43N; R50Xi; NR: 36/37/38-43-50S: (2-)25-36/37-46-61C ≥ 20 %: Xi, N; R36/37/38-43-502,5 % ≤ C < 20 %: Xi, N; R43-501 % ≤ C < 2,5 %: Xi; R43
613-280-00-Xtetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;dimethyl propyleneurea230-625-67226-23-5Repr. Cat. 3; R62Xn; R22Xi; R41XnR: 22-41-62S: 26-36/37/39
613-281-00-5quinolineE202-051-691-22-5Carc. Cat. 2; R45Muta. Cat. 3; R68Xn; R21/22Xi; R36/38N; R51-53T; NR: 45-21/22-36/38-68-51/53S: 53-45-61
613-282-00-0triticonazole (ISO);(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol131983-72-7N; R51-53NR: 51/53S: 61
613-283-00-6ketoconazole;1-[4-[4-[[(2SR,4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanoneE265-667-465277-42-1Repr. Cat. 2; R60T; R25Xn; R48/22N; R50-53T; NR: 60-25-48/22-50/53S: 53-45-60-61
613-284-00-1metconazole (ISO);(1RS,5RS;1RS,5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol125116-23-6Repr. Cat. 3; R63Xn; R22N; R51-53Xn; NR: 22-63-51/53S: (2-)36/37-46-61
613-285-00-71-hydroxybenzotriazole, anhydrous; [1]1-hydroxybenzotriazole, monohydrated [2]219-989-7 [1]219-989-7 [2]2592-95-2 [1]123333-53-9 [2]E; R2ER: 2S: 16-35
613-286-00-2potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;[containing < 0,5 % N,N-dimethylformamide (EC No 200-679-5)]418-260-2183196-57-8R43XiR: 43S: (2-)24-37
613-286-01-Xpotassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]418-260-2183196-57-8Repr. Cat. 2; R61R43TR: 61-43S: 53-45
613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3Xn; R22R43N; R51-53Xn; NR: 22-43-51/53S: (2-)24-37-61
613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5Xn; R22Xi; R41R52-53XnR: 22-41-52/53S: (2-)22-26-37/39-61
613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1N; R50-53NR: 50/53S: 60-61
613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9Xi; R41R43N; R50-53Xi; NR: 41-43-50/53S: (2-)24-26-37/39-60-61
613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0Xn; R48/22N; R50-53Xn; NR: 48/22-50/53S: (2-)22-36-60-61
613-292-00-5N,N′,N″-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3Muta. Cat. 3; R68R52-53XnR: 68-52/53S: (2-)36/37-61
613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester448-050-6444065-11-6R53R: 53S: 61
613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9R53R: 53S: 61
613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]thiazepine hydrochloride448-720-8363138-44-7Xn; R22Xi; R41R52-53XnR: 22-41-52/53S: (2-)22-26-39-61
613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7R43R52-53XiR: 43-52/53S: (2-)24-37-47-61
613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6R10Xn; R22N; R51-53Xn; NR: 10-22-51/53S: (2-)16-61
613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6Xn; R48/22Xi; R41N; R51-53Xn; NR: 41-48/22-51/53S: (2-)22-26-36/39-61
613-299-00-3main component 1 (isomer 1): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 1 (isomer 2): 2-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-3-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 2: 2,3-bis-{6-fluoro-4-[3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt;main component 3: 2,3-bis-{6-fluoro-4-[3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino]-1,3,5-triazin-2-ylamino}-propane sodium salt422-610-1Xi; R41XiR: 41S: (2-)22-26-39
613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3R43R53XiR: 43-53S: (2-)24-37-61
613-301-00-2dimethyl-1-{[2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]methyl} imidazole-4,5-dicarboxylate443-910-7R53R: 53S: 61
613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Xi; R41XiR: 41S: (2-)22-26-39
613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1N; R50-53NR: 50/53S: 60-61
613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7Xn; R22Xi; R41XnR: 22-41S: (2-)22-26-39
613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1R53R: 53S: 61
613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1Xn; R22R43N; R51-53Xn; NR: 22-43-51/53S: (2-)24-37-61
613-307-00-5clothianidin (ISO);3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine210880-92-5Xn; R22N; R50-53Xn; NR: 22-50/53S: (2-)46-60-61C ≥ 25 %: Xn, N; R22-50/532,5 % ≤ C < 25 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51/530,025 % ≤ C < 0,25 %: R52/53
613-308-00-02-amino-5-methylthiazole423-800-57305-71-7Xn; R22-48/22N; R50-53Xn; NR: 22-48/22-50/53S: (2-)22-36-60-61
613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2Xn; R21/22Xi; R38-41R52-53XnR: 21/22-38-41-52/53S: (2-)26-36/37/39-61
613-310-00-1(-)(3S,4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6Xn; R22R43N; R50-53Xn; NR: 22-43-50/53S: (2-)22-24-37-60-61
613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6Xn; R22Xi; R36R43R52-53XnR: 22-36-43-52/53S: (2-)22-24-26-37-61
613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5Xn; R22Xi; R41R43R52-53XnR: 22-41-43-52/53S: (2-)22-26-36/37/39-61
613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0R52-53R: 52/53S: 61
613-314-00-34-decyloxazolidin-2-one;4-decyl-1,3-oxazolidin-2-one443-770-77693-82-5N; R50-53NR: 50/53S: 22-24-60-61
613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1Xn; R20R52-53XnR: 20-52/53S: (2-)25-61
613-316-00-4trimethylopropane tri(3-aziridinylpropanoate);(TAZ)H257-765-052234-82-9Muta. Cat. 3; R68Xi; R41R43XnR: 41-43-68S: 26-36/37/39-42
615-044-00-14-chlorophenylisocyanate203-176-9104-12-1T+; R26Xn; R22Xi; R37/38-41R42N; R50-53T+; NR: 22-26-37/38-41-42-50/53S: (1/2-)26-28-36/37/39-45-63-60-61
615-045-00-74,4′-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1R42/43R53XnR: 42/43-53S: (2-)23-24-37-45-61
616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7Xn; R22-48/22R52-53XnR: 22-48/22-52/53S: (2-)22-36/37-61
616-164-00-7dimoxystrobin (ISO);(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide149961-52-4Carc. Cat. 3; R40Repr. Cat. 3; R63Xn; R20N; R50-53Xn; NR: 20-40-63-50/53S: (2-)36/37-46-60-61C ≥ 25 %: Xn, N; R20-40-63-50/535 % ≤ C < 25 %: Xn, N; R40-63-50/532,5 % ≤ C < 5 %: Xn, N; R40-50/531 % ≤ C < 2,5 %: Xn, N; R40-51/530,25 % ≤ C < 1 %: N; R51/530,025 % ≤ C < 0,25 %: R52-53
616-165-00-2beflubutamid (ISO);(RS)-N-benzyl-2-(α,α,α,4-tetrafluoro-m-tolyoxy)butyramide113614-08-7N; R50-53NR: 50/53S: 60-61C ≥ 0,25 %: N; R50/530,025 % ≤ C < 0,25 %: N; R51/530,0025 % ≤ C < 0,025 %: R52/53
616-166-00-8cyazofamid (ISO);4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide120116-88-3N; R50-53NR: 50/53S: 60-61C ≥ 2,5 %: N; R50/530,25 % ≤ C < 2,5 %: N; R51-530,025 % ≤ C < 0,25 %: R52/53
616-167-00-3N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4Xi; R36R43XiR: 36-43S: (2-)24-26-37
616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2R43XiR: 43S: (2-)22-24-37
616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7R43R53XiR: 43-53S: (2-)24-37-61
616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2Xi; R36R43XiR: 36-43S: (2-)22-26-36/37
616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5Xi; R41R43XiR: 41-43S: (2-)24-26-37/39
616-172-00-0N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl423-840-314691-89-5Xn; R22XnR: 22S: (2-)22
616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1Xn; R22Xi; R36XnR: 22-36S: (2-)22-26
616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3R53R: 53S: 61
616-176-00-23-N,N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7Xn; R22R52-53XnR: 22-52/53S: (2-)22-24-61
616-177-00-8(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;N-[3-({4-[(2-{butyl[(4-methylphenyl)sulfonyl]amino}phenyl)thio]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl}amino)-4-chlorophenyl]tetradecanamide432-970-1217324-98-6R53R: 53S: 61
616-178-00-3N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4R53R: 53S: 22-61
616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5Xi; R41R43N; R50-53Xi; NR: 41-43-50/53S: (2-)22-26-36/37/39-60-61
616-180-00-4N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9Repr. Cat. 2; R61N; R50-53T; NR: 61-50/53S: 53-45-60-61
616-181-00-X4′-methyldodecane-1-sulfonanilide435-490-917417-32-2N; R50-53NR: 50/53S: 60-61
616-182-00-5N′-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1R43N; R51-53Xi; NR: 43-51/53S: (2-)24-37-61
616-183-00-0N-dodecyl-4-methoxybenzamide442-340-61854-15-5R53R: 53S: 61
616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8R53R: 53S: 61
616-186-00-7N,N′-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4R52-53R: 52/53S: 61
616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9R43R53XiR: 43-53S: (2-)24-37-61
616-189-00-3N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9R53R: 53S: 61
616-190-00-9N-decyl-4-nitrobenzamide445-880-064026-19-3R53R: 53S: 61
616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0Xn; R22Xi; R36/38R43N; R51-53Xn; NR: 22-36/38-43-51/53S: (2-)24-26-37-61
616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5′-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2′-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9R53R: 53S: 61
616-193-00-5N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9R53R: 53S: 61
616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Xi; R36XiR: 36S: (2-)26
616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4N; R50-53NR: 50/53S: 60-61
616-197-00-7mixture of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide422-500-1Xn; R48/22XnR: 48/22S: (2-)22-36
616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7R43R53XiR: 43-53S: (2-)24-37-61
616-200-00-1mixture of: N,N′-ethane-1,2-diylbis(hexanamide);12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;N,N′-ethane-1,2-diylbis(12-hydroxyoctadecanamide)432-430-3R43R53XiR: 43-53S: (2-)24-37-61
616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6Xn; R20R53XnR: 20-53S: (2-)22-61
616-202-00-2mixture of: 2,2′-[(3,3′-dichloro[1,1′-biphenyl]-4,4′-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;2-[[3,3′-dichloro-4′-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1′-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide434-330-5Carc. Cat. 3; R40R43R53XnR: 40-43-53S: (2-)36/37-61
616-203-00-8mixture of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide442-280-0R53R: 53S: 61
616-204-00-3N,N″-(methylenedi-4,1-phenylene)bis[N′-octylurea]451-060-3122886-55-9R53R: 53S: 61
617-022-00-7mixture of: 1,2-dimethylpropylidene dihydroperoxide;dimethyl 1,2-benzenedicarboxylate442-480-8O; R7Xn; R22C; R34R43N; R51-53O; C; NR: 7-22-34-43-51/53S: (1/2-)3/7-14-26-36/37/39-45-50-61
647-017-00-5laccase420-150-480498-15-3R42XnR: 42S: (2-)23-45
ANNEX 1CThe entries in Annex I with the following Index numbers are deleted:024-004-01-4, 603-037-01-3, 603-155-00-8, and 611-084-00-9.